DTC
RPTX

Deep Track Capital’s Repare Therapeutics RPTX Stock Holding History

Deep Track Capital’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-904,261
Closed -$2.98M – 79
2024
Q2 		$2.98M Sell
904,261
-1,780,083
-66% -$6.35M 0.09% 63
2024
Q1 		$12.6M Sell
2,684,344
-308,387
-10% -$1.98M 0.36% 49
2023
Q4 		$21.8M Sell
2,992,731
-75,000
-2% -$420K 0.73% 46
2023
Q3 		$37.1M Buy
3,067,731
+340,125
+12% +$3.51M 1.43% 24
2023
Q2 		$28.9M Hold
2,727,606
– – 1.34% 23
2023
Q1 		$26.8M Hold
2,727,606
– – 1.1% 31
2022
Q4 		$40.1M Sell
2,727,606
-400,061
-13% -$5.98M 1.68% 23
2022
Q3 		$37.9M Buy
3,127,667
+420,005
+16% +$5.41M 1.74% 19
2022
Q2 		$37.9M Buy
2,707,662
+43,645
+2% +$514K 2.49% 16
2022
Q1 		$37.9M Buy
2,664,017
+564,017
+27% +$8.36M 2.43% 15
2021
Q4 		$44.3M Buy
+2,100,000
New +$49.5M 3.13% 9

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deep Track Capital's RPTX Position: Q3 2024 in Review

Deep Track Capital sold out of Repare Therapeutics (RPTX) in Q3 2024, closing a stake of 904,261 shares — an estimated $2.98M sold.

Deep Track Capital first reported a position in RPTX in Q4 2021 and held it in 11 quarters. The position peaked at $44.3M in Q4 2021. 56 funds tracked by Wall St. Rank hold RPTX as of Q3 2024.

  • Deep Track Capital reported no remaining Repare Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Deep Track Capital sold 904,261 Repare Therapeutics shares in Q3 2024, an estimated $2.98M.
  • Deep Track Capital first reported a position in Repare Therapeutics in Q4 2021 and held it in 11 quarters.
  • Deep Track Capital's Repare Therapeutics position peaked at $44.3M in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2024.

Based on Deep Track Capital's 13F filing for Q3 2024, filed 14 Nov 2024.